Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study

OBJECTIVES: To investigate the association of alkaline phosphatase (ALP) levels with the risk of the composite end point of cardiovascular disease (CVD), and all-cause mortality as well as each of them separately. DESIGN: Prospective cohort study. SETTING: Within the framework of the Tehran Lipid an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ Open
Auteurs principaux: Kabootari, Maryam, Raee, Mohammad Reza, Akbarpour, Samaneh, Asgari, Samaneh, Azizi, Fereidoun, Hadaegh, Farzad
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2018
Sujets:
Cardiovascular Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254490/
https://ncbi.nlm.nih.gov/pubmed/30478120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-023735
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires